Cognitive behavior therapy for diabetes distress, depression, health anxiety, quality of life and treatment adherence among patients with type-II diabetes mellitus: a randomized control trial

Abstract

Objective Diabetes distress typically causes depressive symptoms; common comorbidity of diabetes unpleasantly affects patients’ medical and psychological functions. Psychotherapeutic interventions are effective treatments to treat depressive symptoms and to improve the quality of life in many chronic diseases including diabetes. The present study investigated the efficacy of cognitive behavior therapy (CBT) to treat depressive symptoms in patients with type 2 diabetes mellitus (T2DM) using experimental and waitlist control conditions. Materials and Methods A total of 130 diagnosed patients with T2DM were taken from outdoor patients services of different hospitals in Faisalabad. Ninety patients met the eligibility criteria and were randomly assigned to experimental (n = 45) and waitlist control (n = 45) conditions. All the patients completed clinical interviews and assessment measures at pre-and post-assessment stages (16 weeks intervals). Medical consultants at the respective hospitals diagnosed the patients on the base of their medical reports and then referred those patients to us. Then we used different scales to assess primary and secondary outcomes: Diabetes Distress Scale (DDS) and Patient Health Questionnaire (PHQ) to assess primary outcomes, and a Short Health Anxiety Inventory (SHAI), a Revised Version of the Diabetes Quality of Life Questionnaire (DQLQ), and a General Medication Adherence Scale (GMAS) were used to investigate secondary outcomes. Repeated measure ANOVA was used to analyze the results. Results The findings indicated that patients who received CBT got a significant reduction in their diabetes distress F(1,60) = 222.710, P < 0.001, η2 = .788), depressive symptoms F(1,60) = 94.436, P < 0.001, η2 = .611), health anxiety F(1,60) = 201.915, P < .0.001, η2 = 771), and a significant improvement in their quality of life F(1,60) = 83.352, P < 0.001, η2 = .581), treatment adherence F(1,60) = 67.579, P < 0.001, η2 = .566) and physical activity schedule F(1,60) = 164.245, P < .0.001, η2 = .736 as compared to the patients in waitlist control condition. Conclusion It is concluded that cognitive behavior therapy is an effective and promising intervention for depressive symptoms, diabetes distress, and health anxiety which also helps the person to promote quality of life, treatment adherence and physical activity.

Addressing depression in older adults with Alzheimer’s through cognitive behavioral therapy: systematic review and meta-analysis

“…Cognitive behavioral therapy is a type of intervention that has attracted the attention of multiple researchers in recent years. Various studies have highlighted the effects of this intervention in participants with insomnia ( Zhang et al, 2023 ), prostate cancer ( Kemerer et al, 2023 ), type II diabetes mellitus ( Abbas et al, 2023 ) and atherosclerotic cardiovascular disease ( Li et al, 2023 ) among others. In addition, CBT has been observed to improve other psychological variables in participants with a diagnosis of AD, such as anxiety, a common coexisting complaint that has a significant negative impact on such participants ( Kraus et al, 2008 ).…”

Exploring the viability of newer technologies in care and management of tribal diabetes and metabolic syndrome in India

“…It also targets mental and behavioural barriers to diabetes management, improving one's psychological state and reducing stress levels. 28 Also, it is particularly effective as it takes the unique cultural practices and beliefs of tribal populations into account, making it a more appropriate option that fits their lifestyle. It imparts individuals with the necessary skills for self-care and enables them to gain control over the condition, which can be crucial in areas with limited resources.…”

Mental health screening in patients with type-2 diabetes mellitus

“…At the end, the answers for each item are added up and divided by the number of questions in each sphere of distress; if the result is 2-2.9 there is moderate distress, if it is greater than 3 there is high distress and intervention is needed. 35,100,108,109 Qasir Abbas (2023), used in his randomized controlled clinical trial the PHQ scale and the DSS to evaluate the intervention of cognitivebehavioral therapy in the management of anxiety due to diabetes, depression and anxiety in patients with type 2 DM and concluded that the intervention improved depressive symptoms F(1.60) = 94.436, P < 0.001, and anxiety symptoms F(1.60) = 201.915, P < 0.001 (110) SRQ: This scale allows screening for mental disorders from the age of 16, it has 30 questions; each question has a yes or no answer option.…”